全血治疗失血:损害控制中的止血复苏。

Pub Date : 2020-12-30 DOI:10.25100/cm.v51i4.4511
Juan Carlos Salamea-Molina, Amber Nicole Himmler, Laura Isabel Valencia-Angel, Carlos A Ordoñez, Michael W Parra, Yaset Caicedo, Mónica Guzmán-Rodríguez, Claudia Orlas, Marcela Granados, Carmenza Macia, Alberto García, José Julián Serna, Marisol Badiel, Juan Carlos Puyana
{"title":"全血治疗失血:损害控制中的止血复苏。","authors":"Juan Carlos Salamea-Molina, Amber Nicole Himmler, Laura Isabel Valencia-Angel, Carlos A Ordoñez, Michael W Parra, Yaset Caicedo, Mónica Guzmán-Rodríguez, Claudia Orlas, Marcela Granados, Carmenza Macia, Alberto García, José Julián Serna, Marisol Badiel, Juan Carlos Puyana","doi":"10.25100/cm.v51i4.4511","DOIUrl":null,"url":null,"abstract":"<p><p>Hemorrhagic shock and its complications are a major cause of death among trauma patients. The management of hemorrhagic shock using a damage control resuscitation strategy has been shown to decrease mortality and improve patient outcomes. One of the components of damage control resuscitation is hemostatic resuscitation, which involves the replacement of lost blood volume with components such as packed red blood cells, fresh frozen plasma, cryoprecipitate, and platelets in a 1:1:1:1 ratio. However, this is a strategy that is not applicable in many parts of Latin America and other low-and-middle-income countries throughout the world, where there is a lack of well-equipped blood banks and an insufficient availability of blood products. To overcome these barriers, we propose the use of cold fresh whole blood for hemostatic resuscitation in exsanguinating patients. Over 6 years of experience in Ecuador has shown that resuscitation with cold fresh whole blood has similar outcomes and a similar safety profile compared to resuscitation with hemocomponents. Whole blood confers many advantages over component therapy including, but not limited to the transfusion of blood with a physiologic ratio of components, ease of transport and transfusion, less volume of anticoagulants and additives transfused to the patient, and exposure to fewer donors. Whole blood is a tool with reemerging potential that can be implemented in civilian trauma centers with optimal results and less technical demand.</p>","PeriodicalId":0,"journal":{"name":"","volume":"51 4","pages":"e4044511"},"PeriodicalIF":0.0,"publicationDate":"2020-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/15/1657-9534-cm-51-04-e4044511.PMC7968429.pdf","citationCount":"0","resultStr":"{\"title\":\"Whole blood for blood loss: hemostatic resuscitation in damage control.\",\"authors\":\"Juan Carlos Salamea-Molina, Amber Nicole Himmler, Laura Isabel Valencia-Angel, Carlos A Ordoñez, Michael W Parra, Yaset Caicedo, Mónica Guzmán-Rodríguez, Claudia Orlas, Marcela Granados, Carmenza Macia, Alberto García, José Julián Serna, Marisol Badiel, Juan Carlos Puyana\",\"doi\":\"10.25100/cm.v51i4.4511\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Hemorrhagic shock and its complications are a major cause of death among trauma patients. The management of hemorrhagic shock using a damage control resuscitation strategy has been shown to decrease mortality and improve patient outcomes. One of the components of damage control resuscitation is hemostatic resuscitation, which involves the replacement of lost blood volume with components such as packed red blood cells, fresh frozen plasma, cryoprecipitate, and platelets in a 1:1:1:1 ratio. However, this is a strategy that is not applicable in many parts of Latin America and other low-and-middle-income countries throughout the world, where there is a lack of well-equipped blood banks and an insufficient availability of blood products. To overcome these barriers, we propose the use of cold fresh whole blood for hemostatic resuscitation in exsanguinating patients. Over 6 years of experience in Ecuador has shown that resuscitation with cold fresh whole blood has similar outcomes and a similar safety profile compared to resuscitation with hemocomponents. Whole blood confers many advantages over component therapy including, but not limited to the transfusion of blood with a physiologic ratio of components, ease of transport and transfusion, less volume of anticoagulants and additives transfused to the patient, and exposure to fewer donors. Whole blood is a tool with reemerging potential that can be implemented in civilian trauma centers with optimal results and less technical demand.</p>\",\"PeriodicalId\":0,\"journal\":{\"name\":\"\",\"volume\":\"51 4\",\"pages\":\"e4044511\"},\"PeriodicalIF\":0.0,\"publicationDate\":\"2020-12-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/15/1657-9534-cm-51-04-e4044511.PMC7968429.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.25100/cm.v51i4.4511\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.25100/cm.v51i4.4511","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

失血性休克及其并发症是创伤患者死亡的主要原因。事实证明,采用损伤控制复苏策略来处理失血性休克可降低死亡率并改善患者预后。止血复苏是损伤控制复苏的组成部分之一,包括以 1:1:1:1 的比例使用包装红细胞、新鲜冰冻血浆、低温沉淀物和血小板等成分来补充失去的血容量。然而,这一策略在拉丁美洲许多地区和世界其他中低收入国家并不适用,因为这些地区缺乏设备齐全的血库,血液制品供应不足。为了克服这些障碍,我们建议使用冷新鲜全血对失血患者进行止血复苏。厄瓜多尔 6 年多的经验表明,与使用血液成分复苏相比,使用冷新鲜全血进行复苏具有相似的效果和安全性。与成分血疗法相比,全血具有许多优点,包括但不限于输注生理成分比例的血液、便于运输和输血、输给患者的抗凝剂和添加剂量较少、接触的献血者较少。全血是一种具有重新崛起潜力的工具,可在民用创伤中心使用,并能达到最佳效果和较低的技术要求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
Whole blood for blood loss: hemostatic resuscitation in damage control.

Hemorrhagic shock and its complications are a major cause of death among trauma patients. The management of hemorrhagic shock using a damage control resuscitation strategy has been shown to decrease mortality and improve patient outcomes. One of the components of damage control resuscitation is hemostatic resuscitation, which involves the replacement of lost blood volume with components such as packed red blood cells, fresh frozen plasma, cryoprecipitate, and platelets in a 1:1:1:1 ratio. However, this is a strategy that is not applicable in many parts of Latin America and other low-and-middle-income countries throughout the world, where there is a lack of well-equipped blood banks and an insufficient availability of blood products. To overcome these barriers, we propose the use of cold fresh whole blood for hemostatic resuscitation in exsanguinating patients. Over 6 years of experience in Ecuador has shown that resuscitation with cold fresh whole blood has similar outcomes and a similar safety profile compared to resuscitation with hemocomponents. Whole blood confers many advantages over component therapy including, but not limited to the transfusion of blood with a physiologic ratio of components, ease of transport and transfusion, less volume of anticoagulants and additives transfused to the patient, and exposure to fewer donors. Whole blood is a tool with reemerging potential that can be implemented in civilian trauma centers with optimal results and less technical demand.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1